The latest LifeSci SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
LifeSci II Amends Prospectus on $75M IPO
Related Posts
Pine Technology Acquisition Completes $345M IPO
The SPAC intends to concentrate its efforts on identifying businesses in the insurance-related technology sector.
Isleworth Healthcare Acquisition Seeks Deadline Extension
The SPAC earlier this month terminated a merger agreement with Cytovia Holdings that was valued at $602 million.
First Light Acquisition Group Sets Vote Next Month for Deadline Extension up to a Year
While the SPAC said it is "currently in discussions regarding various business combination opportunities," there won't be enough time to reach an agreement, much less complete a deal, before the current Sept. 14 deadline.
DTRT Health Acquisition Files for $200M IPO
The new SPAC plans to target the healthcare industry, specifically home and community based healthcare services.